Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype
- PMID: 11454804
- PMCID: PMC1728417
- DOI: 10.1136/gut.49.2.263
Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype
Abstract
Background: Genotype 1b of hepatitis C virus (HCV) comprises mainly three subtypes, each named for its geographic prevalence (worldwide, W; Japan, J; and not in Japan, NJ).
Aim: To characterise the newly identified subtypes of genotype 1b and to review factors associated with response to interferon (IFN) for each subtype.
Patients: Chronic hepatitis patients (80 men and 41 women; mean age 48.5 years, range 20.7--69.3) with HCV genotype 1b (W type, n=41; J type, n=38) or genotype 2a (n=42) were treated according to the same IFN protocol. Forty four patients (36.4%) negative for serum HCV RNA six months after cessation of treatment were considered complete responders.
Methods: Factors associated with complete response were investigated.
Results: Genotype 2a patients had lower viral loads (odds ratio 0.11 (95% confidence intervals (CI) 0.049--0.256)) and a better IFN response (odds ratio 0.25 (95% CI 0.117--0.552)) than genotype 1b patients whereas W type and J type patients had similar viral loads and responses to IFN. IFN response in W type patients was associated with female sex (odds ratio 0.23 (95% CI 0.055--0.983)) and low viral load (odds ratio 84.00 (95% CI 14.04--502.6)) whereas response in J type patients was related to transfusion history (odds ratio 7.20 (95% CI 1.443--35.91)), low viral load (odds ratio 117.0 (95% CI 17.82--768.3)), and genetic mutation in the interferon sensitivity determining region of the virus (odds ratio 0.08 (95% CI 0.013--0.553)). Multivariate analysis found low viral load (odds ratio 64.19 (95% CI 14.66--281.06)) to be the only significant independent factor associated with IFN response.
Conclusions: Factors associated with IFN responsiveness in HCV infection differ with viral subtype.
Similar articles
-
Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.Hepatobiliary Pancreat Dis Int. 2005 May;4(2):213-9. Hepatobiliary Pancreat Dis Int. 2005. PMID: 15908318 Clinical Trial.
-
Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.J Med Virol. 2009 Mar;81(3):459-66. doi: 10.1002/jmv.21407. J Med Virol. 2009. PMID: 19152412
-
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1B.J Med Virol. 2007 Jan;79(1):35-40. doi: 10.1002/jmv.20766. J Med Virol. 2007. PMID: 17133546
-
High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.J Gastroenterol. 2004;39(2):155-61. doi: 10.1007/s00535-003-1266-9. J Gastroenterol. 2004. PMID: 15069622 Clinical Trial.
-
Heterogeneity of hepatitis C virus.Baillieres Clin Gastroenterol. 1996 Jul;10(2):243-55. doi: 10.1016/s0950-3528(96)90005-6. Baillieres Clin Gastroenterol. 1996. PMID: 8864032 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources